Dyne Therapeutics DYN
NASDAQ DYN
$16.51 +0.30 (+1.85%)
As of: Sep 30, 2026 · 10:03 AM EDT

Dyne Therapeutics (DYN) Preferred Shares (2019)

Updated

Dyne Therapeutics (DYN) posted Preferred Shares of $27.43 million for Q4 2019.

Analysis

Dyne Therapeutics (DYN) Preferred Shares (2019) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn -
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn -
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Dyne Therapeutics 2.71 Bn 2.71 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 27.43 Mn
API Access

Dyne Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=DYN&period=max&api_key=YOUR_API_KEY